Credit Suisse expects Q2 and full-year organic sales growth of +9.2% and +10.1% (against a Visible Alpha consensus of +7.5/+9.1%), underpinned by solid pricing, resilient trends in Europe and the reopening of certain Asian regions, offsetting disappointing trends in the US and China.

In the Americas (CSe +6.4% organic sales in Q2), Credit Suisse expects +5% growth in the US. In Asia and the rest of the world (CSe Q2 +13.7%), the analyst is targeting single-digit growth in China. ' However, this is offset by continued strong growth in India, Africa/Middle East ' stresses the analyst firm.

Credit Suisse recently upgraded its opinion on the stock to outperform with a price target of 230 E.

' Our organic sales and EBIT growth of +8.9% and 9.4% for fiscal 2023 is unchanged, and compares with consensus +7.4%/+7.5%. We are not making any significant changes to estimates; our EPS is +4% versus consensus', says Credit Suisse.

Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.